TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+70.2%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+70.2%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
4.9x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 164.88% |
| 2024 | -86.62% |
| 2023 | 55.52% |
| 2022 | 33.47% |
| 2021 | 152.03% |
| 2020 | -106.44% |
| 2019 | 0.00% |